statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)

In trading on Thursday, shares of HilleVax Inc (HLVX) crossed below their 200 day moving average of 14.56, changing hands as low as 14.46 per share. HilleVax Inc shares are currently...

HLVX Crosses Below Key Moving Average Level

HC Wainwright reissued their buy rating on shares of HilleVax (NASDAQ:HLVX  Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $28.00...

HilleVax (NASDAQ:HLVX) Given Buy Rating at HC Wainwright

HilleVax, Inc. (NASDAQ:HLVX  Get Free Report) Director Aditya Kohli sold 6,000 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average...

Aditya Kohli Sells 6,000 Shares of HilleVax, Inc. (NASDAQ:HLVX) Stock

HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation...

HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation

Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 Enrollment for NEST-IN1 study completed in Q2 2023 $303.5 million of cash, cash equivalents and...

HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress

Swiss National Bank lifted its stake in HilleVax, Inc. (NASDAQ:HLVX  Free Report) by 47.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange...

Swiss National Bank Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX)

HilleVax, Inc. (NASDAQ:HLVX  Get Free Report) CFO Shane Maltbie sold 3,576 shares of the firms stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an...

Insider Selling: HilleVax, Inc. (NASDAQ:HLVX) CFO Sells $53,389.68 in Stock

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

Volume	52,392.00
52-Wk High	$20.22
52-Wk Low	$9.94

HLVX HilleVax Inc

About

Feed

News

Sentiment

Earnings

Fundamentals